Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134606) titled 'Uterine Artery Chemoimmunoembolization Combined with Radiotherapy in Locally Advanced Cervical Cancer(CIETAI-LACC): A Phase II Single-Arm Trial' on Oct. 16.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Chongqing Qianjiang Central Hospital
Condition:
Locally advanced cervical cancer (LACC) refers to tumors that are confined to the cervix but have a diameter of = 4 cm, or have invaded beyond the uterus to adjacent organs (vagina, parametrium), or have regional lymph node metastasis, which corresponds to the 2018 FIGO staging of cervical cancer at stages IB3, IIA2, IIB to IVA.
Rec...